Ogeda (Belgium)

Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial

Herman Depypere, D. Timmerman, Gilbert Donders et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 151 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia

Thomas Suply, Sébastien Hannedouche, Nathalie Carte et al. · Science Signaling · 2017 · 95 citations

Life Sciences, Immunology, Molecular Biology +16

Assessment of a Urinary Kidney MicroRNA Panel as Potential Nephron Segment-Specific Biomarkers of Subacute Renal Toxicity in Preclinical Rat Models

Stéphanie Glineur, Étienne Hanon, Sarah Dremier et al. · Toxicological Sciences · 2018 · 15 citations · Full text

Medicine, Pharmacology, Toxicology +14

Clinical evaluation of the NK3 receptor antagonist fezolinetant (a.k.a. ESN364) for the treatment of menopausal hot flashes

Herman Depypere, D. Timmerman, Gilbert Donders et al. · Maturitas · 2017 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +13

Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury

Jana Obajdin, Mabel Cotter, Sara Snelling et al. · Toxicological Sciences · 2018 · 12 citations · Full text

Medicine, Biochemistry, Pharmacology +16